Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-09

Clinical Trial Update: Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the traditional Chinese medicine combination Lingzhi and Sen Miao San for rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lingzhi and Sen Miao San

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED